Given COL1A2’s pivotal role in ECM remodeling and FAK’s essential function in integrin-mediated signal transduction, we evaluated the impact of FAK inhibition on COL1A2-driven invasiveness in SW1710 bladder cancer cells. The gene discussed is COL1A2; the disease is urinary bladder cancer.